ProPhase Labs Inc.

NASDAQ: PRPH · Real-Time Price · USD
0.34
-0.02 (-5.03%)
At close: Jun 09, 2025, 3:59 PM

ProPhase Labs Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
6.77M 44.38M 122.65M 79.04M
Cost of Revenue
6.92M 28.14M 51.99M 46.23M
Gross Profit
-150K 16.24M 70.65M 32.81M
Operating Income
-38.63M -21.61M 23.59M 9.8M
Interest Income
n/a 78K 153K 642K
Pretax Income
-42.33M -22.8M 22.91M 5.3M
Net Income
-53.36M -16.78M 18.46M 6.27M
Selling & General & Admin
37.88M 34.5M 46.41M 22.49M
Research & Development
594K 1.42M 652K 520K
Other Expenses
n/a 1.93M 46.41M n/a
Operating Expenses
38.48M 37.85M 47.06M 23.01M
Interest Expense
3.35M 1.27M 764K 1.15M
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
45.4M 66M 99.05M 69.24M
Income Tax Expense
7.2M -6.02M 4.45M -968K
Shares Outstanding (Basic)
19.08M 17.21M 15.85M 15.17M
Shares Outstanding (Diluted)
19.08M 17.21M 18.65M 18.39M
EPS (Basic)
-2.43 -0.98 1.17 0.41
EPS (Diluted)
-2.43 -0.98 1.02 0.40
EBITDA
-32.34M -14.83M 28.73M 11.39M
EBIT
-38.98M -21.52M 23.67M 6.45M
Depreciation & Amortization
6.64M 6.7M 5.06M 4.93M